Free Trial

NRx Pharmaceuticals (NRXP) SEC Filings & 10K Form

NRx Pharmaceuticals logo
$2.28 -0.17 (-6.94%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$2.34 +0.06 (+2.63%)
As of 02/21/2025 06:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent NRx Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/20/2025
9:57 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B3
02/03/2025
3:40 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
4:10 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
8:24 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B3
01/22/2025
3:32 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
3:12 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:32 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:27 AM
Javitt Jonathan C (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
12:44 PM
ABRAMS MICHAEL S (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2024
8:00 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:24 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
11:21 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/31/2024
7:00 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
3:52 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:53 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:18 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form DEF 14A
08/20/2024
3:38 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
4:27 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
3:39 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
4:15 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
3:58 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
6:37 PM
McBride Dennis (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2024
4:03 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
4:26 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:46 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 10-K/A
04/19/2024
4:10 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2024
9:08 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
04/18/2024
7:21 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
04/15/2024
4:22 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
4:13 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B3
04/15/2024
5:00 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B3
04/02/2024
5:01 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
4:18 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2024
4:09 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:08 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form DEFA14A
03/11/2024
4:16 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form DEF 14A
02/28/2024
4:09 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
9:40 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
02/26/2024
4:15 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NRXP) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners